Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
6.13
-0.01 (-0.16%)
Jul 11, 2025, 11:47 AM EDT

Knight Therapeutics Revenue

Knight Therapeutics had revenue of 88.08M CAD in the quarter ending March 31, 2025, with 1.70% growth. This brings the company's revenue in the last twelve months to 372.78M, up 12.21% year-over-year. In the year 2024, Knight Therapeutics had annual revenue of 371.30M with 13.13% growth.

Revenue (ttm)
372.78M
Revenue Growth
+12.21%
P/S Ratio
1.64
Revenue / Employee
500.37K
Employees
745
Market Cap
611.71M

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 371.30M 43.11M 13.13%
Dec 31, 2023 328.20M 34.64M 11.80%
Dec 31, 2022 293.56M 50.09M 20.57%
Dec 31, 2021 243.48M 43.96M 22.03%
Dec 31, 2020 199.52M 152.06M 320.39%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition